TY - JOUR T1 - <span hwp:id="article-title-1" class="article-title">Continuous glucose monitoring improved glycaemic control in pregnant women with diabetes and reduced infant macrosomia</span><span hwp:id="article-title-2" class="sub-article-title">Commentary</span> JF - Evidence Based Nursing JO - Evid Based Nurs SP - 43 LP - 43 DO - 10.1136/ebn.12.2.43 VL - 12 IS - 2 AU - Beverley O'Brien Y1 - 2009/04/01 UR - http://ebn.bmj.com/content/12/2/43.abstract N2 - H R MurphyDr H R Murphy, University of Cambridge, Cambridge, UK; hm386@medschl.cam.ac.ukDoes continuous glucose monitoring (CGM) improve glycaemic control in pregnant women with diabetes and reduce infant macrosomia?Design:randomised controlled trial. Current Controlled Trials ISRCTN84461581.Allocation:concealed.Blinding:unblinded.Follow-up period:to delivery.Setting:2 diabetes antenatal clinics in the UK.Patients:71 pregnant women (mean age 31 y, mean gestational age 9 wks) who had type 1 diabetes (65% of women) or type 2 diabetes (35%) treated with insulin.Intervention:CGM plus standard antenatal care (n = 38) or standard care alone (n = 33). CGM was done every 4–6 weeks until 32 weeks of gestation. A subcutaneous sensor, attached to a portable monitor, was implanted by a nurse into the woman’s hip and worn for 5–7 days. The device recorded average tissue glucose concentrations every 5 minutes, but results … ER -